Literature DB >> 9192667

Effect of tissue factor deficiency on mouse and tumor development.

J R Toomey1, K E Kratzer, N M Lasky, G J Broze.   

Abstract

Previous reports suggest that tissue factor (TF) may play an essential role in embryonic vascular development and tumor angiogenesis. To further examine this relationship, the morphology of fully developed TF-deficient embryos and the growth of TF-deficient teratomas and teratocarcinomas were analyzed. In a 129/Sv genetic background, TF null embryos do not survive beyond mid-gestation. In contrast, 14% of 129/Sv x C57BL/6 TF-deficient embryos escape this early mortality and survive to birth. On gross and microscopic inspection, these late gestation, TF-deficient embryos appear normal. The growth and vascularity of TF(+/+), TF(+/-), and TF(-/-) teratomas and teratocarcinomas are indistinguishable. Thus, tumor-derived TF is not required for tumor growth and angiogenesis and the combined data do not support an essential role for TF in embryonic vascular development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192667      PMCID: PMC21260          DOI: 10.1073/pnas.94.13.6922

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Effects of interleukin-1, lipopolysaccharide, and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells.

Authors:  T A Drake; M Pang
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

2.  Serum stimulation of quiescent human fibroblasts induces the synthesis of tissue factor mRNA followed by the appearance of tissue factor antigen and procoagulant activity.

Authors:  L J Bloem; L Chen; W H Konigsberg; R Bach
Journal:  J Cell Physiol       Date:  1989-05       Impact factor: 6.384

3.  Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.

Authors:  T A Drake; J H Morrissey; T S Edgington
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

4.  Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.

Authors:  P P Nawroth; D A Handley; C T Esmon; D M Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc.

Authors:  L F Lau; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

Review 6.  Tissue factor and hemostasis.

Authors:  Y Nemerson
Journal:  Blood       Date:  1988-01       Impact factor: 22.113

7.  Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active.

Authors:  E Camerer; J A Rottingen; J G Iversen; H Prydz
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

8.  Lipid A as the biologically active moiety in bacterial endotoxin (LPS)-initiated generation of procoagulant activity by peripheral blood leukocytes.

Authors:  J Niemetz; D C Morrison
Journal:  Blood       Date:  1977-06       Impact factor: 22.113

9.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; W Fiers; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

10.  A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor.

Authors:  S Hartzell; K Ryder; A Lanahan; L F Lau; D Nathan
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

View more
  20 in total

1.  Xenotransplantation as a model of integrated, multidisciplinary research.

Authors:  Emanuele Cozzi; Erika Bosio; Michela Seveso; Domenico Rubello; Ermanno Ancona
Journal:  Organogenesis       Date:  2009-01       Impact factor: 2.500

2.  Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms.

Authors:  Joseph S Palumbo; Kathryn E Talmage; Jessica V Massari; Christine M La Jeunesse; Matthew J Flick; Keith W Kombrinck; Zhiwei Hu; Kelley A Barney; Jay L Degen
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

3.  Proliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesions.

Authors:  E Pillebout; M Burtin; H T Yuan; P Briand; A S Woolf; G Friedlander; F Terzi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domain.

Authors:  G C Parry; N Mackman
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

5.  Low levels of tissue factor are compatible with development and hemostasis in mice.

Authors:  G C Parry; J H Erlich; P Carmeliet; T Luther; N Mackman
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

6.  Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.

Authors:  D N Müller; E M Mervaala; R Dechend; A Fiebeler; J K Park; F Schmidt; J Theuer; V Breu; N Mackman; T Luther; W Schneider; D Gulba; D Ganten; H Haller; F C Luft
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.

Authors:  Chloe C Milsom; Joanne L Yu; Nigel Mackman; Johann Micallef; G Mark Anderson; Abhijit Guha; Janusz W Rak
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

8.  Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations.

Authors:  Nathalie Magnus; Delphine Garnier; Brian Meehan; Serge McGraw; Tae Hoon Lee; Maxime Caron; Guillaume Bourque; Chloe Milsom; Nada Jabado; Jacquetta Trasler; Rafal Pawlinski; Nigel Mackman; Janusz Rak
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-11       Impact factor: 11.205

9.  The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation.

Authors:  Fumiaki Banno; Anil K Chauhan; Koichi Kokame; Jin Yang; Shigeki Miyata; Denisa D Wagner; Toshiyuki Miyata
Journal:  Blood       Date:  2008-12-24       Impact factor: 22.113

10.  Sharing tissue factor: a winning strategy in tumorigenesis.

Authors:  L Vijaya Mohan Rao; Usha R Pendurthi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.